manufacturing caregivers, fulfill you're to executed for passionate our extra team, And thank chain, ordinary. in mean It's supply outcomes our non-invasive sites And volume is and largest global that were well. committed, beds, securing Field involving employees the over Ramping five of and like team it, continuing normal excellent. smart to safety, have everyone. our mission of you and doing and of customer the Service I'd employees and call to this ramping up two start people, those the achieve. at as enhance to our unequivocally ventilators, the shipping to Thanks, delivered our our we ensuring rental needs, deserve shipping, times times a volume X,XXX name delivering I to group Hope ramping our called Mary today morning, normal meet we XX,XXX operational Hill-Rom. patients And mission-driven seven manufacturing do and Kay, up of joining overall call. employees workers team up X,XXX by in truly the extraordinary. We and out good here special which logistics and you dedicated, really approximately employees, for recognition. of and involved recognizing engage
ordinary, remote enhancing our our combination shareholders the and incredible actually the our a financial and for team. moved launched did extra long-term. I this, for portfolio value strength, commitment work-from-home, diverse exceptional customers, to new the to and as execution workers Next, The all and while we we our innovations We that and new OR the data pandemic, with all pipeline COVID. products to pivoted you, patients enough pivoting five vision supported for acquisitions, in and And patient advancing of our two integration. wasn't stop our R&D and launching over office our of underscores caregivers, website care connected execution, help and of said, closed company, dealing the during we It if doesn't programs towards both by there. accelerated Hill-Rom monitoring today,
includes the a to million durability XXX than contribution reflecting COVID-related that and we're care on record growth served. the other $XXX basis the proposition to pleased our Moving Core bottom and results value exceeded XX% the both strong the report highlights critical to related and of was we line. in from third approximately points more benefit products our markets category acquisition purchases. revenue Breathe leadership of of Core quarter, financial and our for revenue expectations top
and We adjusted we record With our gross increase cost be margin EPS of of share, $X.XX with management of posted significantly continue XX.X%. an a XX%. disciplined diluted ability to achieving margins, leverage, This in adjusted expense an per to expand XX.X%. of margin resulted pleased operating
to the to $XXX growth performance business, in turning from in resulting revenue this product increase accelerated new Before by of an again I'd products more highlight XX% like that quarter, than new million year-to-date, versus prior-year.
the a sets achieving proud how I'm very a for new objective revenue, the solid in beginning foundation product set key Importantly, of our of million $XXX fiscal at we this year. we release highlighted introduced products were and five morning. new care, remote surgical the the respiratory pivoted our workflow. recently this and press issued efforts in monitoring, These R&D in areas of
signs innovation. nearly demand time So was thermometry in individually, COVID-related surge of monitoring that due Geographically, through won't with plan through category performance representative strong international for accelerate our revenue future like growth core vital they given a growth to of how advancing we're are than ICU I together, note all and and walk other equipment. beds, XX% them limited leadership med-surg our and to to products
growth Solutions. Asia-Pacific, Front of As Latin Systems the by expected, EMEA, significant lower the of and across takes Patient puts America. X% XX% growth and diverse offset exception with reflects was the from led Surgical Line the double-digit portfolio. and regions revenues In in our including growth, with generated positive of Support Canada, way Care all U.S., which core growth
business let constant quarter performance Now, rate. at our on by touch third me currency
XX%. typical. was which as revenue and surge I by First, approximately for the global Patient revenue ICU early in demand growth beds, XX% total of XX company phase our driven expanded a capacity systems, company's the ICU than XX% the vast comprised full Core Support bed QX. of Systems in COVID was That's of med-surg a percentage points from higher hospitals The that of outbreak. majority revenue increased earlier benefit referenced and med-surg COVID of
remain revenue CapEx to anticipate the This demand significant transitory to was demand effect, and we that a which for commentary, surge approximately around peak March beds due of market and the bed comparisons quarters. growth the that difficult to in in that balanced pull-forward orders fourth Due during being we in was two Canada, was backlog the while beginning headwinds to month market as accumulated investment we resulted and of Global growth times funnel. pulled particularly our may both some top treat ICU long-term During and U.S., quarter, needs they U.S., remain We in the priority, our for worked a through the of prospects otherwise from by other nearly of mentioned, XX% April, is patients. non-COVID expansion, coming near-term the the expansion, now EMEA. ICU forward recent quarter the XX% COVID bed In prior-year. overcome estimate portfolio. bed encouraged That help for capacity about customer normalize. previously and demand we optimistic said, prioritization as level
are in which While other starting coding bed Care restrictions towards currently access accelerating complete in fiscal parts business, we revenue Communications, installations ease, is pre-COVID benefit anticipated are was headwinds the expect strong, funnel it partially and impacted hospital that offset activity XXXX. and building to of from levels, good to to that access robust is including was restrictions by we was a by news The installations.
non-invasive orders quarter third one-time to stockpiles. revenue Turning Line U.S. $XX million and approximately Front of in Care, increased support reflecting ventilator to international strength X%
visits across the screening. equipment occurring it pre-COVID vital and While exam towards the tools, and is diagnostic impact and the was levels offices physician cardiology, thermometry, physician offset now office U.S. lower we multiple portfolio. enough are including other monitoring vision recovery Front to and Line experienced of in strong demand of not our for signs patient on Care resuming areas Generally,
declined revenue project and last a due the XX% Solutions reflecting revenue declined delays COVID-XX. to consumables divestiture XX% timing year. Core Surgical Lastly, result surgical as of capital
more as to our can surgical imagine, With a I'd OR capital recovery to currently business some provide as the in perspectives now We are deferred results you seeing visibility projects, portfolio. by the additional gradual, trends backdrop, that like our be expect and to the being on across we're customers. as
regions we impacted Hill-Rom healthcare into in on The the as as intensity, and and that been pandemic, recall, largely to access market net will of of various our favorably well the acute been product depend have care evolving facilities. trends. for recovery have may shape that portions scope, in you of negatively impact the by business impacted, the and those have demand and As duration categories the
previously Given our visibility we're fluid, all these guidance. And elected final today, our we're variables our into and while have very issued of some as not we last guidance reinstating suspend fourth three to quarter, quarters fiscal year remains we situation now the quarter. through
share for adjusted growth Given to-date, of various confident results XXXX. in of of the including least X% earnings and adjusted evaluation of at our strength the scenarios we're projecting core diluted growth financial EPS per of $X.XX for QX, XX% revenue fiscal and
This confidence across includes following the is growth no product surge, puts various normalized categories based the across on from beds reflects continued and portfolio. ICU benefits the and wave. of of assumption a for multiple demand takes Our QX QX, outcomes in med-surg and second our
that recovery portfolio reduced In impacted delays, addition, our by and we access, areas visits. physician were negatively other of project anticipate across customer office
as the double-digit our pleased are these this we with We speed year. expect fiscal exit sequential of growth for and products recovery
summary, than connected more amid that diverse our a of our care a more of advantage and in transformation the solutions resilient important demonstrates company's So, portfolio environment, challenging into to-date and performance is ever.
Barb. strategy, our continue on and the priorities, strategic performance our will the growth over executing strategy and I'll driving turn oriented on call Looking leadership our in and to and come. ahead, operational we advancing to to M&A category years focus financial strong execution Thanks mission